Erythromycin was recovered in high yield after incucation with gram-negative bacteria. The cell-free protein-synthesizing preparation from gram-negative bacteria is equally as susceptible to the antibiotic as is that from gram-positive bacteria. Thus, neither destruction of erythromycin nor the absence of the step susceptible to the antibiotic plays an important role in the resistance mechanism of gram-negative bacteria. A 100-fold d fference in accumulation of erythromycin between gram-positive and gram-negative bacteria was observed. This alone explains the resistance of gram-negative bacteria to erythromycin. Furthe-more, data showed that the inhibition of growth is closely related to the accumulation of erythromycin. The concentration of intracellular erythromycin in gram-positive bacteria was found to be 44-to 90-fold greater than that of the extracellular medium. However, the antibiotic did not accumulate on the cell walls, nor was the accumulation energy-dependent. It is proposed that it takes place by the binding of erythromycin to the bacterial ribosomes, forming a very stable complex. The dissociation constants of erythromycin-Staphylococcus aureus complex and erythromycin-Bacillus subtilis complex were determined to be 1.1 X 10-7 and 3.4 X 11-7 M, respectively.
The mechanisms for bacterial resistance to antibiotics can be classified into three categories (8) : (i) destruction of the antibiotic, (ii) absence of the step susceptible to the antibiotic, and (iii) impermeability to the drug. No systematic study of resistance mechanisms of gram-negative bacteria to erythromycin has been reported. Although Haight and Finland (2) showed that erythromycin incubated with Escherichia coli and Proteus vulgaris still was biologically active, no attempt was made to quantitate the recovery or to identify the recovered compound. As to resistance mechanism (ii), it is generally accepted that erythromycin inhibits protein synthesis (13; Mao, Abstr. Interscience Conference on Antimicrobial Agents and Chemotherapy, 6th, p. 43, 1966 ) by binding to ribosomes (6, 12) . There is evidence (9, 15) that protein synthesis in E. coli cell-free preparations can be inhibited by erythromycin, and Tanaka et al. (10) have reported that erythromycin can bind to E. coli ribosomes. Relative to mechanism (iii), Taubeneck (11) found that a stable L form of a P. mirabilis strain was susceptible to erythromycin, but the parent culture with the intact cell wall was 1,000-fold more resistant. These reports indicate that the erythromycin resistance in gram-negative bacteria probably is due to the impermeability of the cell to the antibiotic.
To extend and validate the previous observations, a comparison was made between two gram-negative (E. coli, P. vulgaris) and two grampositive (Staphylococcus aureus, Bacillus subtilis) bacteria, considering all three resistance mechanisms. The accumulation of erythromycin in gram-positive bacteria was further investigated.
MATERIALS AND METHODS Materials. N-'4C-methyl-erythromycin was synthesized by reductive methylation of des-N-methylerythromycin (1), and purified by countercurrent distribution. The product was chromatographically pure on silica gel thin-layer plates in three solvent systems (7) , had a specific activity of Cultures. E. coli ATCC 11775, P. vulgaris ATCC 7897, S. aureus 209P, and B. subtilis ATCC 10707 were grown in Erlenmeyer flasks overnight at 34 C in 3.7% Brain Heart Infusion broth (Difco). The 50% inhibition concentration of erythromycin for these microorganisms is 2 X 10-5, 5 X 10-5, 3 X 10-7, and 2 X 10-7 M, respectively, under our experimental conditions. Samples of 1 ml were inoculated into flasks containing 125 ml of fresh medium and grown until the optical density at 550 mp, reached 0.2 to 0.3. Most of the experiments were conducted in this early log phase. One optical density unit is approximately equivalent to 3 X 108 bacteria per ml.
Recovery of 14C-erythromycin from cultures. 14C-erythromycin (100/Ag) was added to 100 ml of bacterial culture in Brain Heart Infusion broth. After incubation for 30 min at 34 C, the culture was chilled in an ice bath, and the erythromycin was extracted with ethyl ether at pH 9.0 (four times, 100 ml each time 14C-erythromycin uptake by bacteria. The uptake of '4C-erythromycin from the extracellular medium by bacteria was measured by filtering a 5-ml sample of the bacterial suspension through a glass-fiber filter (Reeve Angel, 984H Ultra, 24-mm diameter). The cells were filtered free from medium by suction, and were washed four times with 5 ml of nonradioactive erythromycin solution (10 pg/ml). The radioactivity became constant after three washes. The bacterial cells washed with Brain Heart Infusion broth containing 10 pug of cold erythromycin per ml gave similar results. The absorption of '4C-erythromycin on the filter could be minimized by washing the filter with 5 ml of nonradioactive erythromycin solution before the filtration of bacteria. A filter absorption curve with various concentrations of "4C-erythromycin was constructed to determine the background absorption. It was found that 2.8 X 10-12 moles of 14C-erythromycin was absorbed by the filter when 5 ml of 1.36 X 10-6 M '4C-erythromycin solution was filtered. The absorption of 14C-erythromycin by a membrane filter (HA, 0.45-p.; Millipore Corp., Bedford, Mass.) was about four times higher than by the glass-fiber filter. Adsorption of '4C-erythromycin on isolated cell walls of S. aureus and B. subtilis was determined either by the filtration method described above, or, alternatively, after incubation with 'IC-erythromycin, the cell walls were recovered by centrifugation and resuspended in a nonradioactive erythromycin solution four times.
Formation of the erythromycin-ribosome complex.
The reaction mixture contained 120 p,/Amoles of S.
aureus or E. coli ribosomes and various amounts of 14C-erythromycin in 0.5 ml of buffer solution (0.01 M Tris-acetate, pH 7.6, 0.016 M magnesium acetate, 0.05 M ammonium acetate, and 0.0001 M dithiothreitol). The reaction mixtures were incubated at 34 C for 30 min, diluted with 3 ml of the cold buffer solution, filtered through a nitrocellulose membrane filter (B-6, 25 mm; Schleicher & Schuell Co., Keene, N.H.), and washed with three 3-ml portions of cold buffer solution. A filter adsorption curve was constructed at various concentrations of 4C-erythromycin and used to calculate the net binding of 14C-erythromycin to the ribosomes.
RESULTS
Recovery and identification of erythromycin from gram-negative bacterial cultures. 14C-erythromycin incubated with E. coli and P. vulgaris for 30 min at 34 C was recovered in yields of 97 and 93%, respectively. The recovered compound had RF values identical to erythromycin in three solvent systems, it had antibacterial activity, and the radioactivity was concurrent with the spot test for erythromycin (7) .
Comparison of sensitivity to erythromycin of E. coli and S. aureus in cell-free protein-synthesizing preparations. The effect of erythromycin on the endogenous messenger ribonucleic acid (mRNA)-directed incorporation of "4C-amino acids, poly A-directed incorporation of "4C-lysine, and poly U-directed incorporation of 14C_ phenylalanine was tested with the cell-free extracts from E. coli and S. aureus. The results (Fig. 1) indicate that there is no significant difference between E. coli and S. aureus extracts.
Uptake of 14C-erythromycin by gram-positive and gram-negative bacteria. In a culture with increasing concentrations of erythromycin, the uptake of the antibiotic by gram-positive bacteria rapidly reached a saturation concentration of 0.5 X 10-6 M. The uptake of erythromycin by gram-negative bacteria at any concentration was negligible (Fig. 2) .
The time course of erythromycin uptake by bacteria in a medium containing 1.36 X 10-6 M 4C-erythromycin is shown in Fig. 3 (Fig. 3) .
Relation of erythromycin accumulation to growth inhibition of B. subtilis. The amount of '4C-erythromycin accumulation at various concentrations of the antibiotic and the inhibition of growth rate at these concentrations were determined at the end of 30 min of incubation (Fig. 4) . plete after 10 min at 34 C, and further incubation up to 60 mmn had no effect on the complexes. The complexes were very stable, as they remainedintact after three washings with 3 ml of cold buffer. (Fig. 4) . Taubeneck (11) showed that the L form of a P. mirabilis strain is very susceptible to erythromycin, although the parent strain with the intact wall is resistant. Kagan et al. (4) (12) , and E. coli (9) . That the ribosome-erythromycin complex can survive prolonged centrifugation through a drug-free sucrose gradient or through a drugfree column indicates that the complex is very stable. The stability of the ribosome-erythromycin complex is quantitated by the dissociation constants of the complexes. The dissociation constants are indeed very small (2.8 X 10-6 and 3.6 X 10-6 M for S. aureus and E. coli, respectively). The dissociation constants of bacteria-erythromycin are 1.1 X 10-7 and 3.4 x 10-v M for S. aureus and B. subtilis. The discrepancy between the ribosome-erythromycin dissociation constants and the bacteria-erythromycin constants probably reflects that in bacterial cells there is a small fraction of erythromycin in addition to that bound to ribosomes.
Tissieres et al. (13) have estimated that one E. coli cell (cell volume about 10-12 ml) at the early log phase contains 90,000 ribosomes. Assuming that the density of ribosomes in B. subtilis and S. aureus is approximately the same as in E. coli, and that each ribosome binds one erythromycin molecule, the intracellular concentration can reach 0.15 mm. This agrees with the 0.06 to 0.12 mm concentration of erythromycin in B. subtilis and S. aureus observed in our studies.
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